Latest Tomotherapy Stories
Stereotactic body radiation therapy (SBRT) stopped the growth of cancer at its original site in the lung for three years among nearly 98 percent of patients with early non-small cell lung cancer (NSCLC) who are unable to have the cancer surgically removed.
KANSAS CITY, Mo., Aug. 26 /PRNewswire/ -- Kansas City Cancer Center (KCCC), an affiliate of US Oncology, Inc.
Only Radiotherapy Department in State of Qatar to Introduce State-of-the-Art Treatments including RapidArc(TM) Technology DOHA, Qatar, March 11 /PRNewswire-FirstCall/ -- One of the leading cancer centers in the Middle East has acquired two advanced radiotherapy devices from Varian Medical Systems (NYSE: VAR) equipped with RapidArc(TM) technology for fast and precise treatments.
HONG KONG, Feb. 17 /PRNewswire-FirstCall/ -- Doctors in Hong Kong have carried out the first treatments in south-east Asia using a new, faster form of radiotherapy that extends more advanced care to more patients.
MILAN, Italy, Jan. 6 /PRNewswire-FirstCall/ -- A pancreatic cancer patient has become the first person in Italy to be treated using a new, faster form of radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients.
Latest bid to force TomoTherapy to consider strategic alternatives MADISON, Wis., Dec. 29 /PRNewswire/ -- Avalon Portfolio, LLC, the investment arm of Avalon Capital Group, announced that on December 23, 2008 it nominated four new directors to serve on the board of TomoTherapy Inc. (Nasdaq: TOMO).
TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Technical University of Munich, Germany, recently welcomed 175 radiation oncology experts from 16 countries to the 'International Conference on the Clinical Use of TomoTherapy'.
Cancer survivors joined Central DuPage Hospital, Radiation Oncology Consultants and ProCure Treatment Centers to break ground on construction of the new Proton Therapy Center of Central DuPage Hospital, a ProCure Center.
TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Grupo IMO of Madrid, Spain, recently hosted a symposium on the clinical use of the Hi-Art(R) treatment system for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).
- Large; stout; burly.